Things are getting pretty heated today! Let's see what this one is capable of. $ARMAQ Amarillo Biosciences, Inc. (OTCBB: ARMAQ) is the world leader in the development of low-dose interferon for oral delivery and has progressed to Phase 2 clinical studies using its unique, patented interferon lozenges to treat human diseases.